EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The Birth Prevalence of Congenital Hyperinsulinism: A Narrative Review of the Epidemiology of a Rare Disease

Tai L S Pasquini, David Lapidus, Diva D De León, Paul S Thornton, Davelyn Hood, Jeffrey Breit, Julie Raskin, Tai L S Pasquini

Hormone Research in Paediatrics · 2024

DOI: 10.1159/000539464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Tai L S Pasquini und 7 weiteren Autor:innen. Beteiligte Einrichtung: LapidusData Inc., Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Congenital Hyperinsulinism, Global Health, Rare Diseases, Infant Health. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Congenital hyperinsulinism (HI) is a rare pediatric disease and the most common cause of severe, persistent hypoglycemia in childhood. It is characterized by the dysregulation of insulin secretion from the pancreas and can lead to irreversible brain damage with lifelong neurodisability. Summary: The global birth prevalence of HI is currently unknown. An evidence-based estimate of HI birth prevalence is essential to improve diagnosis and patient management, to drive clinical research and the development of new treatments, and to inform public policy. In order to estimate the birth prevalence of persistent HI, a targeted literature review of studies that report HI epidemiological data was undertaken, and the strengths and limitations of each study were analyzed. Overall, eight global studies were identified that reported independently determined HI epidemiological data. Key Messages: The best estimate for the birth prevalence of persistent HI in European-ancestry populations is 3.5 per 100,000 births. Local consanguinity patterns appear to have a considerable impact on the birth prevalence of persistent HI in each country, precluding the application of this figure to all global populations. More epidemiological studies with robust methodology are needed to enable a reliable approximation of the incidence and prevalence of HI in global populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital HyperinsulinismGlobal HealthRare DiseasesInfant HealthFemaleHumansInfant, NewbornMalePrevalence

Stichwörter der Autor:innen

Congenital hyperinsulinismEpidemiologyIncidencePrevalence

Autor:innen und Institutionen

  • LapidusData Inc., Oklahoma City, Oklahoma, USA.
  • Congenital Hyperinsulinism Center and Division of Endocrinology and Diabetes, Department of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphi…
  • Congenital Hyperinsulinism Center, Cook Children's Medical Center, Fort Worth, Texas, USA.
  • Rezolute, Inc., Redwood City, California, USA.
  • Congenital Hyperinsulinism International, Glen Ridge, New Jersey, USA.

Zitieren

APA

Pasquini, T. L. S., Lapidus, D., De León, D. D., Thornton, P. S., Hood, D., Breit, J., Raskin, J., & Pasquini, T. L. S. (2024). The Birth Prevalence of Congenital Hyperinsulinism: A Narrative Review of the Epidemiology of a Rare Disease. Hormone Research in Paediatrics. https://doi.org/10.1159/000539464

Vancouver

Pasquini TLS, Lapidus D, De León DD, Thornton PS, Hood D, Breit J, et al. The Birth Prevalence of Congenital Hyperinsulinism: A Narrative Review of the Epidemiology of a Rare Disease. Hormone Research in Paediatrics. 2024. doi:10.1159/000539464

BibTeX
@article{Pasquini2024,
  author = {Pasquini, Tai L S and Lapidus, David and De León, Diva D and Thornton, Paul S and Hood, Davelyn and Breit, Jeffrey and Raskin, Julie and Pasquini, Tai L S},
  title = {The Birth Prevalence of Congenital Hyperinsulinism: A Narrative Review of the Epidemiology of a Rare Disease},
  journal = {Hormone Research in Paediatrics},
  year = {2024},
  doi = {10.1159/000539464}
}
Kostenlos starten →